Description
Inclusion Criteria:
- * Signed and dated study informed consent
- * Documented history of hypertension
- * Documented history of prior or current antihypertensive medication(s)
- * Mean seated office systolic BP at screening ≥ 140 mmHg
- * Mean pre-procedure home systolic BP of ≥ 135 mmHg
- * Estimated glomerular filtration rate (eGFR) of ≥30 mL/min/m2
- RADIANCE CAP patients must provide signed and dated informed consent for inclusion in long-term follow-up. No other criteria are required for inclusion.
Exclusion Criteria:
- Patients who meet the following will be excluded from participation:
- * Patient lacks appropriate renal anatomy for any treatment with the Paradise Catheter
- * Patient under the age of 18 years old at the time of consent
- * Patient is pregnant
- * Patients with transplanted kidney
- * Presence of abnormal kidney (or secreting adrenal) tumors
- To confirm eligibility for treatment with the Paradise System, the following contraindications listed in the IFU may be determined at the time of procedure prior to treatment:
- * Renal arteries with diameter \< 3mm and \> 8mm
- * Renal artery with fibromuscular dysplasia (FMD)
- * Stented renal artery
- * Renal artery aneurysm
- * Renal artery diameter stenosis \>30%
- * Iliac/femoral artery stenosis precluding insertion of the Paradise Catheter
Ages Eligible for Study:
18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
No